Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 8;21(6):e12556.
doi: 10.2196/12556.

Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression

Christine Moberg  1 , Andrea Niles  2 , Dale Beermann  1
Affiliations
Randomized Controlled Trial

Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression

Christine Moberg et al. J Med Internet Res. .

Abstract

Background: Despite substantial improvements in technology and the increased demand for technology-enabled behavioral health tools among consumers, little progress has been made in easing the burden of mental illness. This may be because of the inherent challenges of conducting traditional clinical trials in a rapidly evolving technology landscape.

Objective: This study sought to validate the effectiveness of Pacifica, a popular commercially available app for the self-management of mild-to-moderate stress, anxiety, and depression.

Methods: A total of 500 adults with mild-to-moderate anxiety or depression were recruited from in-app onboarding to participate in a randomized waitlist controlled trial of Pacifica. We conducted an all-virtual study, recruiting, screening, and randomizing participants through a Web-based participant portal. Study participants used the app for 1 month, with no level of use required, closely mimicking real-world app usage. Participants in the waitlist group were given access to the app after 1 month. Measurements included self-reported symptoms of stress, anxiety, depression, and self-efficacy. We performed an intent-to-treat analysis to examine the interactive effects of time and condition.

Results: We found significant interactions between time and group. Participants in the active condition demonstrated significantly greater decreases in depression, anxiety, and stress and increases in self-efficacy. Although we did not find a relationship between overall engagement with the app and symptom improvement, participants who completed relatively more thought record exercises sustained improvements in their symptoms through the 2-month follow-up to a greater degree than those who completed fewer. In addition, we found that participants who reported concomitantly taking psychiatric medications during the trial benefitted less from the app, as measured by the symptoms of anxiety and stress.

Conclusions: This study provides evidence that Pacifica, a popular commercially available self-help app, is effective in reducing self-reported symptoms of depression, anxiety, and stress, particularly among individuals who utilize thought records and are not taking psychiatric medication.

Trial registration: ClinicalTrials.gov NCT03333707; https://clinicaltrials.gov/ct2/show/NCT03333707 (Archived by WebCite at http://www.webcitation.org/78YE07ADB).

Keywords: anxiety; cognitive behavioral therapy; depression; mHealth; smartphone app; stress.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: At the time of this study, CM was the Head of Psychology, owned options in Pacifica Labs, Inc, and was receiving a salary from the company. DB was the Cofounder and CEO of Pacifica Labs, Inc, owned a large share of the company’s stock, and received a salary from the company.

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials diagram.
Figure 2
Figure 2
Key outcome measures by group and time. DASS: Depression Anxiety Stress Scales.
Figure 3
Figure 3
Interaction between use of "Thoughts" tool and anxiety and stress outcomes. DASS: Depression Anxiety Stress Scales.
Figure 4
Figure 4
Moderation of group by time effect by participant self-reported psychiatric medication use. DASS: Depression Anxiety Stress Scales.
See this image and copyright information in PMC

References

    1. National Comorbidity Survey (NCS) 2017. [2019-05-20]. https://www.hcp.med.harvard.edu/ncs/index.php .
    1. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
    1. Beck J. Cognitive Behavior Therapy, Second Edition. New York, NY: Guilford Press; 2011. p. 9781609185046.
    1. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005 Apr;62(4):409–16. doi: 10.1001/archpsyc.62.4.409.62/4/409 - DOI - PubMed
    1. Butler A, Chapman J, Forman E, Beck A. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006 Jan;26(1):17–31. doi: 10.1016/j.cpr.2005.07.003.S0272-7358(05)00100-5 - DOI - PubMed

Publication types

Associated data